首页> Hepatology (Baltimore, Md.)> Tumor-infiltrating, interleukin-33-producing effector-memory CD8(+) T cells in resected hepatocellular carcinoma prolong patient survival.

Tumor-infiltrating, interleukin-33-producing effector-memory CD8(+) T cells in resected hepatocellular carcinoma prolong patient survival.

导出 LinkOut

翻译打印收藏纠错

第一作者： Stefan M,Brunner

第一单位： Department of Surgery, University Medical Center Regensburg, Regensburg, Germany.

作者： Stefan M,Brunner ^[1] ; Christoph,Rubner ^[1] ; Rebecca,Kesselring ^[1] ; Maria,Martin ^[1] ; Eva,Griesshammer ^[1] ; Petra,Ruemmele ^[2] ; Thomas,Stempfl ^[3] ; Andreas,Teufel ^[4] ; Hans J,Schlitt ^[1] ; Stefan,Fichtner-Feigl ^[5]

作者单位： Department of Surgery, University Medical Center Regensburg, Regensburg, Germany. ^[1] Institute of Pathology, University Medical Center Regensburg, Regensburg, Germany. ^[2] Center of Excellence for Fluorescent Bioanalytics, University of Regensburg, Regensburg, Germany. ^[3] Department of Internal Medicine I, University Medical Center Regensburg, Regensburg, Germany. ^[4] Department of Surgery, University Medical Center Regensburg, Regensburg, Germany.;Regensburg Center of Interventional Immunology, University Medical Center Regensburg, Regensburg, Germany. ^[5]